drugset / Trial / NCT02096536

Exploring Vancomycin Disposition in Neonates

NCT02096536

Phase 4 Recruiting 120 enrolled Universitaire Ziekenhuizen KU Leuven
NaSingle-groupOpen-labelBasic science

Summary

Vancomycin is already used for decades in neonates. However, there are remaining questions concerning vancomycin disposition in this population. The purpose of this study is first of all to perform a paired analysis of serum vancomycin concentrations using an immunoassay versus a reference liquid chromatography-tandem mass spectrometry method. Secondly, we aim to determine vancomycin protein binding and its covariates in neonates.

Timeline

Start
2014-04
Primary completion
2025-01
Completion
2025-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Vancomycin Other / unclassified

Indications

No indication recorded.